MIHALOVIC, Michal, Robert PETR, Denisa ODVODYOVÁ, Ivana MALINICOVA, Katerina PILIKOVA, Michal KARPISEK, Jiří JARKOVSKÝ and Zuzana MOTOVSKA. Abstract 13625: Laboratory Markers of Effective Endogenous Fibrinolysis in Intermediate-High-Risk Pulmonary Embolism. In VASCULAR DISEASE AND THROMBOSIS 2023. 2023. ISSN 1346-9843. Available from: https://dx.doi.org/10.1161/circ.148.suppl_1.13625. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{2365655, author = {Mihalovic, Michal and Petr, Robert and Odvodyová, Denisa and Malinicova, Ivana and Pilikova, Katerina and Karpisek, Michal and Jarkovský, Jiří and Motovska, Zuzana}, booktitle = {VASCULAR DISEASE AND THROMBOSIS 2023}, doi = {http://dx.doi.org/10.1161/circ.148.suppl_1.13625}, keywords = {Endogenous Fibrinolysis; High-Risk Pulmonary Embolism;}, language = {eng}, title = {Abstract 13625: Laboratory Markers of Effective Endogenous Fibrinolysis in Intermediate-High-Risk Pulmonary Embolism}, url = {https://www.ahajournals.org/doi/10.1161/circ.148.suppl_1.13625}, year = {2023} }
TY - CONF ID - 2365655 AU - Mihalovic, Michal - Petr, Robert - Odvodyová, Denisa - Malinicova, Ivana - Pilikova, Katerina - Karpisek, Michal - Jarkovský, Jiří - Motovska, Zuzana PY - 2023 TI - Abstract 13625: Laboratory Markers of Effective Endogenous Fibrinolysis in Intermediate-High-Risk Pulmonary Embolism KW - Endogenous Fibrinolysis KW - High-Risk Pulmonary Embolism; UR - https://www.ahajournals.org/doi/10.1161/circ.148.suppl_1.13625 N2 - Introduction: Unselected therapy with fibrinolysis in intermediate risk-pulmonary embolism (iPE) is associated with an unacceptable risk of bleeding. Early identification of iPE patients on anticoagulant therapy with ineffective endogenous fibrinolysis (eFL) could optimize treatment-strategy. Aims: The study aims to determine markers of (in)effective eFL in intermediate-risk PE initially on anticoagulant therapy with UFH. ER -
MIHALOVIC, Michal, Robert PETR, Denisa ODVODYOVÁ, Ivana MALINICOVA, Katerina PILIKOVA, Michal KARPISEK, Jiří JARKOVSKÝ and Zuzana MOTOVSKA. Abstract 13625: Laboratory Markers of Effective Endogenous Fibrinolysis in Intermediate-High-Risk Pulmonary Embolism. In \textit{VASCULAR DISEASE AND THROMBOSIS 2023}. 2023. ISSN~1346-9843. Available from: https://dx.doi.org/10.1161/circ.148.suppl\_{}1.13625.
|